"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.
A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.
mTOR signaling in growth control and disease.
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
Adapting proteostasis for disease intervention.
Mitochondrial diseases in man and mouse.
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
Mitochondria: dynamic organelles in disease, aging, and development.
The endocannabinoid system as an emerging target of pharmacotherapy.
Mammalian sirtuins: biological insights and disease relevance.
ER stress and the unfolded protein response.
Inflammatory mechanisms in obesity.
Five years of GWAS discovery.
Roles of PPARs in health and disease.
HMDB: the Human Metabolome Database.
Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.
The inflammasome NLRs in immunity, inflammation, and associated diseases.
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors.